U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07380295) titled 'Improving Workforce Participation and Well-Being in Individuals With Multiple Sclerosis - A Feasability Study' on Sept. 22, 2025.
Brief Summary: Multiple sclerosis (MS) is a chronic neurodegenerative disease and a leading cause of reduced workforce participation due to neurological illness in Western countries. Over the past 30 years, new treatments have reduced symptom burden, allowing patients to stay in the workforce longer. However, fatigue and cognitive impairments remain major barriers to work capacity. This project aims to preliminary examine the impact of cognitive function on work ability, and assess the role of neuropsychol...